The challenge: Tracking the functional progression and response to therapy of people with Parkinson’s disease and other movement disorders.
The solution: Developing wearable sensors, such as a wristwatch-like device called Opal, the world’s most advanced “gem” in movement monitors, to precisely measure biomedical changes.
Why it matters: Because there are no blood tests or direct methods to measure how certain diseases are progressing in a patient, clinicians and researchers have only been able to rely on subjective observations. Better data means better ability to judge effectiveness of new therapies and a faster path for potential clinical trials.
Where it matters: The research led to the development of a local Portland State startup company that primarily employs alumni. But the reach is global, with systems to support research now being deployed around the world.